These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Majić T; Schmidt TT; Gallinat J J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401 [TBL] [Abstract][Full Text] [Related]
7. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
8. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology. Miceli McMillan R; Fernandez AV Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307 [TBL] [Abstract][Full Text] [Related]
9. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. Hendricks PS Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256 [TBL] [Abstract][Full Text] [Related]
10. Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy. Mocanu V; Mackay L; Christie D; Argento E Subst Abuse Treat Prev Policy; 2022 May; 17(1):37. PubMed ID: 35568884 [TBL] [Abstract][Full Text] [Related]
11. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Greenway KT; Garel N; Jerome L; Feduccia AA Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of therapeutic change after psychedelic treatment in OCD. Maloney G; Ching T; Kichuk SA; Pittenger C; Kelmendi B Psychiatry Res; 2024 Jun; 336():115907. PubMed ID: 38615521 [TBL] [Abstract][Full Text] [Related]
13. Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations. Miceli McMillan R; Jordens C Med Health Care Philos; 2022 Jun; 25(2):225-237. PubMed ID: 35064398 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness. Holoyda B Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796 [TBL] [Abstract][Full Text] [Related]
15. Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies. Fogg C; Michaels TI; de la Salle S; Jahn ZW; Williams MT Exp Clin Psychopharmacol; 2021 Oct; 29(5):539-554. PubMed ID: 34096755 [TBL] [Abstract][Full Text] [Related]
16. Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review. Sharma R; Batchelor R; Sin J J Psychoactive Drugs; 2023; 55(5):612-630. PubMed ID: 36933948 [TBL] [Abstract][Full Text] [Related]
19. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. Garcia-Romeu A; Richards WA Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079 [TBL] [Abstract][Full Text] [Related]
20. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. Michaels TI; Purdon J; Collins A; Williams MT BMC Psychiatry; 2018 Jul; 18(1):245. PubMed ID: 30064392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]